Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease-Reference-Cited by-同舟云学术

Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease

Published:2017-09-01 Issue:4 Volume:59 Page:671-674
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Harada Ryuichi,Ishiki Aiko,Kai Hideaki,Sato Naomi,Furukawa Katsutoshi,Furumoto Shozo,Tago Tetsuro,Tomita Naoki,Watanuki Shoichi,Hiraoka Kotaro,Ishikawa Yoichi,Funaki Yoshihito,Nakamura Tadaho,Yoshikawa Takeo,Iwata Ren,Tashiro Manabu,Sasano Hironobu,Kitamoto Tetsuyuki,Yanai Kazuhiko,Arai Hiroyuki,Kudo Yukitsuka,Okamura Nobuyuki

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference15 articles.

1. Tau PET Imaging in Alzheimer’s Disease

2. Tau imaging: early progress and future directions

3. Aβ-amyloid and tau imaging in dementia;Villemagne;Semin Nucl Med,2017

4. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease

5. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain;Ng;Alzheimers Res Ther,2017

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET brain imaging in neurological disorders;Physics of Life Reviews;2024-07

2. Increased Uptake of 18F-THK5351 in Isocitrate Dehydrogenase-Wildtype Glioblastoma But Not in Meningioma;Clinical Nuclear Medicine;2024-07-01

3. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy;Neurochemical Research;2024-06-06

4. Recent developments and challenges in positron emission tomography imaging of gliosis in chronic neuropathic pain;Pain;2024-05-07

5. Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer’s Disease;The Journal of Prevention of Alzheimer's Disease;2024